Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: HMA (Heads of Medicines Agencies)
marbofloxacin 100 mg/ml
Vetoquinol
QJ01MA93
Solution for injection
marbofloxacin
Cattle
2008-10-19
12219 MARB OCY L S Renewal FR/V/0168/01/R/01 SPC D 90 January 2011 1/12 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT The UK, Ireland, Marbocyl Solo 10% solution for injection for cattle Spain Marbocyl Bovinos 100 mg/ml solution for injection for cattle Germany, Austria, The Netherlands, Belgium, Italy, Poland, Portugal, The Slovak Republic, The Czech Republic, Greece, Luxembourg, France Marbocyl S 10% solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: Active substance : Marbofloxacin ..................... 100.0 mg Excipients : Disodium edetate. ................... 0.1 mg Thioglycerol ........................... 1.0 mg metacresol ............................. 2.0 mg For a full list of excipients, see section 6.1.” 3. PHARMACEUTICAL FORM Solution for injection. Yellow greenish to yellow brownish, clear solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle 4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Therapeutic treatment of respiratory infections caused by sensitive strains of _Pasteurella _ _multocida_, _Mannheimia haemolytica_ and _Histophilus somni_. 4.3 CONTRA-INDICATIONS Do not use in animals with known hypersensitivity to fluoroquinolones. Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). 4.4 SPECIAL WARNING FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local Perskaitykite visą dokumentą